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PURPOSE. To assess the relationship between cone spacing and visual acuity in eyes with rod-
cone degeneration (RCD) followed longitudinally.
METHODS. High-resolution images of the retina were obtained using adaptive optics scanning
laser ophthalmoscopy from 13 eyes of nine RCD patients and 13 eyes of eight healthy subjects
at two sessions separated by 10 or more months (mean 765 days, range 311–1935 days). Cone
spacing Z-score measured as close as possible (average <0.258) to the preferred retinal locus
was compared with visual acuity (letters read on the Early Treatment of Diabetic Retinopathy
Study [ETDRS] chart and logMAR) and foveal sensitivity.
RESULTS. Cone spacing was significantly correlated with ETDRS letters read (q ¼ 0.47,
95%CI 0.67 to 0.24), logMAR (q ¼ 0.46, 95%CI 0.24 to 0.66), and foveal sensitivity (q ¼
0.30, 95%CI 0.52 to 0.018). There was a small but significant increase in mean cone
spacing Z-score during follow-up of þ0.97 (95%CI 0.57 to 1.4) in RCD patients, but not in
healthy eyes, and there was no significant change in any measure of visual acuity.
CONCLUSIONS. Cone spacing was correlated with visual acuity and foveal sensitivity. In RCD
patients, cone spacing increased during follow-up, while visual acuity did not change
significantly. Cone spacing Z-score may be a more sensitive measure of cone loss at the fovea
than visual acuity in patients with RCD.
Keywords: adaptive optics scanning laser ophthalmoscopy, retinal degeneration, cones
Rod-cone degeneration (RCD) causes progressive death ofphotoreceptors with consequent vision loss over many
years.1 The slowly progressive nature of RCD makes it
challenging to reliably monitor changes during a period of 1
or 2 years. In RCD, night vision and peripheral vision are lost
earliest, but visual acuity can remain stable and normal until
advanced stages of disease.1 A longitudinal study of patients
with retinitis pigmentosa (RP) followed for 9 years found that
visual acuity had the slowest decline relative to other measures,
such as visual field area and focal electroretinogram (ERG).2 In
addition, foveal measures of visual function demonstrate
increased variability as retinal degeneration progresses.3
Robust, sensitive measures of foveal health and cone loss,
particularly ones that rely on structural measures rather than
subjective psychophysical measures described above, could
facilitate measurement of disease progression in patients with
RCD.
Objective measures of retinal structure have become widely
used because of advances in noninvasive, high-resolution
imaging modalities that can be used to monitor changes in
retinal and foveal topography. Spectral-domain optical coher-
ence tomography (SD-OCT), for example, provides noninva-
sive, cross-sectional measures of retinal structures, including
photoreceptors.4,5 SD-OCT measures of outer retinal thickness
have been shown to correlate with visual field sensitivity in
eyes with RP,6,7 and may provide a useful, objective outcome
measure for clinical trials.4,8 Adaptive-optics scanning laser
ophthalmoscopy (AOSLO) allows for en face visualization of
cone mosaics and measurements of cone spacing and density in
healthy and diseased eyes.9–11 Modern AOSLO systems are
capable of imaging the cone mosaic at the fovea and yield
measures of cone spacing12–18 that are comparable to histologic
studies.19
Objective, structural measures of cone spacing may be more
reliable than functional measures, but they are meaningful for
patients only if visual function correlates with retinal structure.
In cross-sectional studies of RCD patients, increases in cone
spacing at or near the fovea were shown to correlate with
visual acuity declines in a nonlinear way.17,18 Visual acuity
decreased below 20/25 only in patients whose foveal cone
density was 40% to 60% lower than normal, suggesting that
visual acuity is preserved despite significant cone loss and is not
a sensitive measure of foveal cone integrity.17,18 One limitation
of prior cross-sectional studies, however, was that we could not
know the extent to which the low cone densities resulted from
actual cone loss or simply reflected the lower end of the
spectrum of normal variation in cone density.
To understand how acuity changes during degeneration it
would be desirable to track photoreceptor structure and
function over time in the same RCD patients. Intervisit and
interobserver variability in cone spacing measures from AOSLO
images have been quantified in healthy eyes and eyes with RCD;
cone changes measured over time that are greater than baseline
intervisit and interobserver variability are likely to represent
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disease progression in RCD patients.20 In this retrospective
study, we compared foveal cone spacing with best-corrected
visual acuity (BCVA) in patients with RCD and healthy subjects
monitored longitudinally during periods ranging from 10
months to 5 years to characterize changes in foveal structure
and function during disease progression in eyes with RCD.
METHODS
Study Design
Procedures for this study were followed in accordance with
the Declaration of Helsinki, and informed consent was given by
all subjects. The study protocol was approved by the
institutional review boards of the University of California, San
Francisco and the University of California, Berkeley.
Subjects
This retrospective study included healthy adults and patients
with RCD, all with visual acuity of 20/40 or better in whom
cone mosaics were visualized in the foveal region using AOSLO
during two sessions separated by at least 10 months. The
subjects are described in the Table.
Functional Measurements
Visual acuity was measured as the number of letters read
correctly using standard eye charts, according to the Early
Treatment of Diabetic Retinopathy Study (ETDRS) protocol21;
results were also converted to the logMAR. Foveal sensitivity
was measured in decibels from automated static perimetry
measuring macular sensitivity in the central 208 (Humphrey
visual field 10-2 protocol; Carl Zeiss Meditech, Dublin, CA,
USA).
SD-OCT Imaging and Analysis
SD-OCT images (Spectralis HRAþOCT; Heidelberg Engineering,
Vista, CA, USA) were acquired through the foveal center by
asking the patient to look at a central fixation target, such that
the foveal center on OCT scans included the preferred retinal
locus for fixation (PRL). Automated retinal tracking was used to
average 100 B-scans in 208 horizontal and vertical cross
sections through the PRL. Horizontal SD-OCT scans through
the PRL were exported to data analysis software (Igor Pro;
WaveMetrics, Inc., Portland, OR, USA) and manually segment-
ed using subroutines5,6,22–24 to identify boundaries between
the different retinal layers. The specific measurement made for
the purposes of this study was the thickness of the cone outer
segment plus RPE (referred to as OSþ22) at the PRL defined
from AOSLO images as described below.
AOSLO Imaging and Cone Spacing Measurements
Prior to AOSLO imaging, pupils were dilated with 1%
tropicamide and 2.5% phenylephrine. High-resolution images
of the fovea were acquired using a confocal AOSLO system12
and processed into montages as described previously.9 The PRL
for fixation was localized in the AOSLO images by presenting a
target through modulation of the AOSLO scanning raster and
10-second videos were recorded while the patient fixated on
the target.18 The PRL was computed as the centroid of the
scatter plot of the fixated target positions on the retina. AOSLO
images that demonstrated clear cone mosaics at or near the
PRL were compared with precisely aligned and superimposed
SD-OCT scans through the PRL to confirm the cone profiles
corresponded to cross-sectional images with visible external
limiting membrane and inner segment/outer segment or
ellipsoid zone bands, and then were selected for cone spacing.
Customized software was used to determine cone spacing
using previously described methods.9 Other metrics for
analyzing cones in AOSLO images that are potentially more
sensitive than cone spacing were considered25; however,
limited resolution of the AOSLO images acquired near the
fovea in this study necessitated the robustness provided by
cone spacing. In order to most accurately study the cones
involved in fine visual acuity, cone spacing at baseline and
subsequent visits at least 10 months later was measured within
the region of highest cone resolution and closest to the PRL at
each visit. Due to changes in image quality over time, the
region of highest cone resolution that permitted reliable cone
identification was not always the same at the baseline and
follow-up visits. The highest resolution cone spacing location
for each visit was measured as an eccentricity in degrees
relative to the PRL, because we were unable to identify the
exact location of the anatomic fovea (point of maximum cone
density). However, this is a small error because the PRL
location relative to the point of maximum cone density is
reported in the literature to average approximately 35 lm or 7
arcmin.16,26–28 In this manuscript, we assume that offsets
between the PRL and the point of maximum cone density are
no different between RCD patients and normal. To account for
changes between visits in cone spacing with respect to
eccentricity relative to the PRL,19 cone spacing values were
converted to Z-scores, or the number of standard deviations
(SD) from the normal mean (based on 37 age-similar healthy
eyes ranging in age from 14–79 years, mean 36.9 years),18 at
the eccentricity from the PRL where cones were measured.
Our decision to do this rested on an assumption that Z-scores
and changes in Z-scores at the measured location should reflect
similar changes at the PRL. Previous observations of diffuse
changes in cone density throughout the central region in RCD
patients9,11,17,29,30 support this assumption. Z-scores between
2 andþ2 SD were considered normal; Z-scores greater than 2
indicated increased cone spacing due to cone loss. All
measures were acquired at baseline and at least 10 months
later in each eye studied.
Statistical Analysis
Structural measures (cone-spacing Z-scores and OCT measure-
ment of OSþ thickness at the PRL) were compared with each
other using Spearman’s rank correlation q, with 95% confi-
dence intervals that do not contain zero considered statically
significant. Structural measures (cone spacing Z-score and OSþ
thickness) were compared with functional measures, including
ETDRS letters read, logMAR, and foveal sensitivity, at each time
point using Spearman’s rank correlation q with 95% confi-
dence intervals, clustered by individual to account for the fact
that each individual was measured at baseline and follow-up.
The Wilcoxon signed rank test was used to analyze change in
measures over time for each subject with P < 0.05 considered
statistically significant.
RESULTS
Clinical Characteristics
Clinical characteristics of the subjects are shown in the Table.
Thirteen eyes from nine patients with RCD were studied. Of 13
eyes, 11 had RP, one had Usher syndrome type 2C, and one had
Usher syndrome type 3A. Thirteen eyes of eight healthy
subjects were also studied. The nine patients ranged in age
from 28 to 42 years at baseline (mean 35), and the eight
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healthy subjects ranged from 24 to 57 years at baseline (mean
47); the healthy subjects were significantly older than the
patients (Wilcoxon rank sum test with continuity correction
test P ¼ 0.015). AOSLO images were taken at two time points
separated by greater than 10 months (mean 765 days, range
311–1935 days) for each of the eyes. There was no significant
difference in duration of follow-up between patients and
controls (mean follow up in patients ¼ 845.9 days, mean
follow-up in healthy subjects ¼ 736.8 days, Wilcoxon test P ¼
0.49).
Structural Measures
The PRL was used as the origin to compute the eccentricity of
locations where cones were measured and was recorded at
each visit. There was slight variation between baseline and
follow-up in the precise location of the PRL for each AOSLO
image (mean difference ¼ 0.1288, SD ¼ 0.078; average change
in patients ¼ 0.1208, SD ¼ 0.088; average change in control
subjects¼ 0.1358, SD¼ 0.061), which has a minimal effect on
the cone spacing Z-score (mean absolute Z-score change due to
PRL change ¼ 0.151, range 0.0354–0.368). We attribute the
slight change in PRL between visits to a combination of some
variability due to the limited 10-second video duration used to
assess the PRL and slight image registration errors. Figure 1
shows examples of foveal cone images near the PRL, the OCT
B-scan location and segmentation image, and identification of
cones for cone spacing measures in patient 40073; a white
circle indicates the center of mass of the displayed fixational
eye positions at the PRL. Additional foveal cone images near
the PRL for patient 40026 and healthy subject 40051 are shown
in Supplementary Figure S1. Figure 2 plots cone spacing Z-
scores against the distances from the PRL where measures
were made in healthy subjects and patients. The average
eccentricities of the cone spacing measures were slightly
greater at the second visit than the first visit for both healthy
subjects and RCD patients (mean baseline eccentricity¼ 0.218,
mean follow-up eccentricity ¼ 0.278; mean difference for
normal subjects ¼ 0.068, 95%CI 0.14 to 0.0010; mean
difference for patients ¼ 0.078, 95%CI 0.19 to 0.054). Note
that the Z-scores are greater than 0 for most measurements
made closest to the fovea. This is not unexpected in the RCD
patients, but in the healthy eyes we might expect the Z-scores
to average around 0. The increase in Z-scores here reflects our
bias toward selecting healthy eyes with clear and unambiguous
cones near the fovea, which in turn are the eyes in which
spacing falls in the upper range of the normal distribution. It
should be noted that despite the bias, the Z-scores in healthy
eyes are all lower than 2 and therefore fall within the normal
range (Fig. 2). Furthermore, the study focuses on the changes
over time, and we have no reason to believe that this selection
bias will influence that analysis in any way.
There was a small but significant increase in cone spacing Z-
score during follow up in the RCD patients of þ0.97 (95%CI
0.57–1.4), while there was no significant change in Z-score in
healthy eyes (0.070, 95%CI 0.41 to 0.27; Fig. 3, top). Some
patients with the longest follow-up showed little change, while
others with shorter follow-up showed greater change, indicat-
ing variability in the rate of progression. Changes in cone
spacing Z-score for each eye are shown in Supplementary
Figure S2.
Mean SD-OCT OSþ thickness at the PRL was not signifi-
cantly thinner in RCD patients than healthy subjects at baseline
or at follow-up (mean difference between healthy and patients
at baseline¼ 4.2 lm, 97.5% CI0.28 to 8.8 lm; at follow-up¼
4.2 lm, 97.5%CI1.4 to 9.7 lm). SD-OCT OSþ thickness at the
PRL did not change significantly during follow-up in healthy
eyes (þ0.70 lm, 95%CI 1.5 to 3.0 lm, or patients with RCD
[þ0.64 lm, 1.9 to 3.2 lm]; Fig. 3, bottom). SD-OCT OSþ
thickness at the PRL was negatively correlated with cone
spacing Z-score in healthy eyes at baseline (q ¼0.55, 95%CI
0.86 to0.031) and at the follow-up exam (q¼0.64, 95%CI
0.93 to0.17). However, in RCD patients OSþ thickness was
not correlated with Z-score at baseline (q ¼ 0.019, 95%CI
0.55 to 0.47), or follow-up (q¼0.011, 95%CI0.64 to 0.52;
Fig. 4). When all subjects at all dates were aggregated together
there was a significant correlation between OSþ thickness and
Z-score (q ¼0.40, 95%CI 0.67 to 0.087).
Functional Measures
There was no significant change in visual acuity measured as
ETDRS letters read or logMAR or in foveal sensitivity between
imaging sessions in the healthy subjects. Despite a significant
increase in cone spacing Z-score during follow-up in the RCD
patients of þ0.97 (see above) there was no significant change
in letters read (average change 0.71 letters, 95%CI 2.1 to
0.78), logMAR (average change 0.0074, 95%CI 0.043 to
0.024) or foveal sensitivity (average change 0.36 dB, 95%CI
1.56 to 0.88).
Structure Versus Function
When all study subjects and visits were combined, cone
spacing Z-score was significantly correlated with ETDRS
letters read (q ¼0.47, 95%CI 0.67 to 0.24), logMAR (q ¼
0.46, 95%CI 0.26 to 0.66) and foveal sensitivity (q ¼0.30,
FIGURE 1. AOSLO Images of foveal mosaic for RCD patient 40073 at
two time points separated by 36 months, with baseline image to the
top left (A) and follow-up image to the top right (B). AOSLO images
over a larger area are shown at baseline at the bottom left (C) and at
follow-up at the bottom right (D) with the green line depicting the
location of the SD-OCT B-scan and segmented SD-OCT B-scan shown
below. The scale bar is 0.258 and the scales are the same between the
two images. The PRL is indicated by the white circle. Insets to the right
of each image show the cone locations used to compute cone spacing
(red crosses).
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95%CI0.52 to0.018; Fig. 5). LogMAR is not shown because
it is derived from ETDRS letters read. OSþ thickness was not
significantly correlated with ETDRS letters read (q ¼0.11,
95%CI 0.46 to 0.19) or foveal sensitivity when all subjects
and visits were combined (q ¼ 0.026, 95%CI 0.26 to 0.28;
Fig. 6).
Analyzing subgroups and times separately, cone spacing Z-
score was significantly correlated with foveal sensitivity at
baseline (q ¼0.55, 95%CI 0.94 to 0.05) but not follow-up
(q¼0.42, 95%CI0.77 to 0.084) in RCD patients. In healthy
subjects, at baseline there was no significant correlation
between Z-score and foveal sensitivity (q ¼ 0.15, 95%CI
FIGURE 2. Cone spacing Z-score for all baseline measures shown on the left for normal (Nrm) and RCD patients. Cone spacing Z-score plotted
against the distance from the measurement to the AOSLO derived PRL shown in the center. Cone spacing Z-score for all follow-up measures shown
on the right. Cone spacing measures taken at baseline are shown as filled symbols and follow-up measures are shown as open symbols; RCD
patients are shown as orange squares, healthy subjects are shown as blue circles.
FIGURE 3. Change in cone spacing Z-score (top) and change in OSþ thickness (bottom) plotted against the time in months between the first
imaging date and second imaging date. RCD patients are shown with orange squares, normal with blue circles. There was a small, significant
increase in Z-score in RCD patients (average change ¼þ0.97 [95%CI 0.57 to 1.4], while no significant changes were found in healthy subjects
(average change¼0.070, 95%CI0.42 to 0.27). There was no significant change in OSþ thickness in patients with RCD (þ0.64 lm, 95%CI1.9 to
3.2 lm) or healthy subjects (þ0.70 lm, 95%CI 1.5 to 3.0 lm).
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0.57 to 0.79), but there was a significant correlation at follow-
up (q ¼0.62, 95%CI 0.83 to 0.26).
DISCUSSION
This retrospective study is the first to assess longitudinal
changes in foveal cone spacing in patients with RCD and
healthy eyes followed for at least 10 months, and to relate
changes in cone spacing to clinical measures of foveal function
and outer retinal thickness. The results represent an important
continuation of a prior cross-sectional study in RCD patients
that identified a significant, nonlinear correlation between
foveal cone spacing and function.18 Over the course of the
longitudinal study, there was no measurable change in visual
function (VA and foveal sensitivity), yet a small but significant
amount of cone loss was detected. The increase in cone
spacing in RCD patients is consistent with prior reports.11 We
also confirmed that cone spacing Z-score was correlated with
measures of visual function at the fovea.18
FIGURE 4. OSþ thickness compared with cone spacing Z-score. Measures taken on first imaging date shown as filled symbols and follow-up shown
as open symbols; RCD patients are shown as orange squares, healthy subjects are shown as blue circles. SD-OCT OSþ thickness at the PRL was
negatively correlated with cone spacing Z-score in healthy eyes at baseline (q¼0.55, 95%CI0.86 to0.048) and at the follow-up exam (q¼0.64,
95%CI0.93 to0.17). However, in RCD patients OSþ thickness was not correlated with Z-score at baseline (q¼0.019, 95%CI0.55 to 0.47) or
follow-up (q¼0.011, 95%CI0.64 to 0.52). When all subjects at all dates were aggregated together there was a significant correlation between
OSþ thickness and Z-score (q¼0.40, 95%CI0.67 to 0.087).
FIGURE 5. Visual acuity shown as ETDRS letters read (top) and foveal sensitivity (bottom) plotted against cone spacing Z-score. The cone spacing
and visual acuity measures taken on the first imaging dates are in filled symbols and the second imaging dates are in open symbols; RCD patients are
shown as orange squares and healthy subjects shown as blue circles. When all study subjects and visits were combined, cone spacing Z-score was
significantly correlated with ETDRS letters read (q¼0.47, 95%CI0.67 to 0.24) and foveal sensitivity (q¼0.30, 95%CI0.52 to 0.018).
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The current study expanded our investigation with
structural tests by also including OCT. A significant negative
correlation between cone spacing Z-score and OSþ thickness at
the PRL, where cone spacing increased as OSþ thickness
decreased, was found in healthy subjects for both visits, but
not at baseline or follow-up visit for RCD patients. The RCD
patients in this study varied widely in the type and severity of
their disease, which likely resulted in greater variability in the
relationship between Z-score and OSþ thickness at the PRL. As
seen in Figure 4, some patients retained well-preserved outer
segments despite increased cone spacing Z-scores. Due to the
proximity of the locations measured in the current study to the
foveal center, we do not expect rod photoreceptors to have
contributed to the OSþ thickness measures.
OSþ thickness was also compared with functional measures
but was not significantly correlated with ETDRS letters read or
with foveal sensitivity. In contrast, AOSLO-derived cone
spacing Z-scores showed significant correlation with both
visual acuity and foveal sensitivity.
The lack of a correlation might be real, or it could be that
correlation is masked by noise from the measurement itself.
While a full assessment of the noise of each measure is
beyond the scope of this paper, some discussion of it is
warranted. Regarding the functional measures, visual acuity
measures are relatively robust (see later discussion on this
point), but foveal sensitivity measurements reflect both
intratest variability factors, such as neural background noise
levels, and intervariability factors, such as reversible ocular
and neural fluctuations.31,32 In addition, foveal sensitivity
measures become more variable as visual function decreases.
Therefore, RCD patients are more likely to have variable
foveal sensitivity measures than the healthy subjects, which
may explain why there was no correlation found between
cone spacing Z-score and foveal sensitivity at follow-up.
Regarding the AOSLO and SD-OCT structural measures, the
noise in both measures arises for different reasons. The SD-
OCT system has a reported axial resolution of 7 lm and a
pixel resolution of 3.5 lm33 and the OSþmeasurement from
the SD-OCT images used in this study comprised between 13
and 23 pixels. The use of a single trained grader (JLD) to
manually segment a single horizontal B-scan centered on the
PRL provides a further source of imprecision into the OSþ
measures in the present study.5,6,22–24 AOSLO images have
very fine lateral resolution of 0.58 arcmin (~2.5 lm) and
lateral sampling resolution of 0.14 arcmin/pixel (~0.7 lm/
pixel) but the distance between cones ranges from 3.5 to 7
pixels. These limits to cone spacing measurement are
overcome in part by estimates of spacing from a collection
of many intercone spacing measures.9,34 Despite the sources
of noise and their impact, the final result was that structural
cone measures from AOSLO proved to be more strongly
correlated than SD-OCT with visual function in this study.
Limitations
The present study is limited in the number of eyes imaged with
well-resolved cones visible near the fovea and is limited due to
the retrospective nature with varied follow-up duration among
the subjects. The inclusion of cone spacing measures as far
from the PRL as 0.668 was not ideal but was necessary to
ensure accurate visualization and measurement of cone
spacing due to limited resolution of cones at the foveal center
in some eyes. Given that fixation stability generally has a
standard deviation of less than 0.18,35 it is likely that in some
subjects the cones in the retinal area we measured were never
used for the acuity task. The conversion of cone spacing to Z-
scores was done to overcome this limitation. Z-scores indicate
the deviation in standard deviations from normal and are
corrected for eccentricity. In this paper and in previous
reports,9,11,36,37 we have noted greater than normal spacing
and decreased densities throughout the central field of patients
with RCD. The decreases in cone density may not be linear
(i.e., density loss is greater toward the edges of the remaining
visual field), but the degeneration appears to affect the entire
retina, including the fovea, in the RCDs we have reported on to
date.9,11,36–39 As such, we are confident that cone spacing Z-
scores measured close to the fovea reflect cone spacing Z-
scores at the fovea.
We chose to study foveal cones and compare with visual
acuity even though the cone loss and degeneration—and
consequent sensitivity to change—may be greater at the edges
of degeneration. Not only did we do this because we were
interested in foveal structure and function in these patients,
but also because comparing structure and function outside of
the fovea can be difficult. It has proven difficult to
disambiguate cones and rods from other structures in confocal
AOSLO images at the edge of degeneration in RCD patients.40
Unfortunately, at the time that these images were collected
phase-contrast imaging methods, like split-detector AOSLO41
were not available. In addition, whereas visual acuity
represents a precise measure of visual function at the PRL
and we made cone spacing measures as close as possible to the
PRL, we did not have similar confidence that measures of visual
function at the peripheral margins of degeneration would
represent the function of the cones we quantified.
Finally, the fact that the healthy subjects in the current
study were significantly older than the patients could
underestimate the differences in cone spacing between healthy
and patients, because cone density has been reported to be
significantly lower in older, compared with younger, patients.42
Thus, our reports of increased cone spacing in the retinal
degenerations patients may be considered conservative when
compared with significantly older healthy subjects. However,
FIGURE 6. Outer segment plus retinal pigment epithelium and Bruch’s
membrane (OSþ) thickness (lm) plotted against visual acuity shown as
ETDRS letters read (top) and foveal sensitivity (dB) (bottom). The OSþ
and visual acuity measures taken on the first imaging dates are in filled
symbols and the second imaging dates are in open symbols; RCD
patients are shown as orange squares and healthy subjects shown as
blue circles. OSþ thickness was not significantly correlated with ETDRS
letters read (q¼0.11, 95%CI0.46 to 0.19) or foveal sensitivity when
all subjects and visits were combined (q¼0.026, 95%CI0.26 to 0.28).
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RCD is genetically heterogeneous and it is possible that in
some forms of RCD there is nonuniform loss of cones; given
the relatively small number of patients in the present study, we
cannot compare cone patterns among patients with different
genetic forms of retinal degeneration, but this would be an
important question to study in future research.
Redundancy in Foveal Cones
Prior studies have suggested that the relationship between
foveal structural measures and psychophysical measures is not
linear.18,43 Using a theory that establishes resolvability as a
measure directly proportional to the distance between foveal
cones with intact connections to higher visual centers, 20/20
vision can be present with loss of 40% of foveal cones, 20/50
vision is expected with 10% of normal foveal cones, and 20/
200 is expected with 1% of normal foveal cones.43 Recent
studies have used AOSLO to measure cone spacing near the
fovea in eyes with retinal degeneration and have demonstrated
that roughly 50% of cones can be lost before visual acuity
declines below 20/25.17,18 Because clinical visual acuity can
remain normal as foveal cone spacing increases, there is likely
to be redundancy in foveal cones for high contrast and fine
detail visual acuity tasks. The present results provide in vivo,
longitudinal data to support predictions that cone density can
decrease significantly before it manifests as a measurable
decrease in visual acuity.
It is important to note that visual acuity is affected by more
than just retinal sampling. Visual acuity integrates everything
that occurs along the visual processing pathway, and each
stage from where light first enters the eye to the generation of
the visual percept can affect it. Moving from low- to high-order
effects, the stages that govern visual acuity include (1) blur
caused by imperfections in the eye’s optics (low- and high-
order aberrations),44 (2) photoreceptor sampling, which is the
focus of this study, (3) retinal ganglion cell receptive fields,
which are generally considered to not impose a bottleneck for
foveal vision in healthy eyes, but remodeling of the retinal in
eye disease could change that,45 (5) fixational eye movements,
which have been shown to confer a benefit to foveal visual
acuity,46 and finally (6) all the post retinal, neural factors that
can limit or interpret the sensory signals that come from the
eye. These all need to be considered collectively to fully
explain how acuity is preserved despite considerable cone
loss.
Subtle Changes Need Finer Tools
Coupled with the redundancy in foveal cones to buffer the loss
of visual impairment in eyes with RCD, the rate of decline in
foveal vision in patients with retinal degeneration is slow.47–49
Moreover, factors such as the differences in patterns of visual
field loss,50,51 genetic causes of RCD, and environment1 may
also contribute to variability in the rate of photoreceptor
degeneration. Taken together, sensitive, objective measures of
photoreceptor survival, such as cone spacing Z-scores from
AOSLO images, may be more useful to monitor photoreceptor
degeneration at the fovea than standard clinical measures, such
as visual acuity, which are insensitive measures of disease
progression in RCD. Foveal cone spacing measures may not be
the most sensitive measurement of degeneration, especially in
patients where cones are lost from the periphery inward;
however, foveal cone degeneration will ultimately have the
strongest effect on visual function and the patient’s most
precious cones. More sensitive tools may identify significant
cone loss before changes in visual acuity and allow for earlier
treatment to reduce disease progression as treatments become
available. In a study that compared cone spacing in RCD
patients treated with sustained-release ciliary neurotrophic
factor (CNTF) with sham-treated contralateral eyes, there was a
significant increase in cone spacing and a reduction in cone
density in the sham-treated RCD eyes, by 2.9% and 9.1%,
respectively, over 24 to 36 months.11 However, there was no
significant change in visual acuity in either the CNTF- or sham-
treated eyes.11 Not only does this study reinforce the need for
sensitive tools to diagnose and track disease progression of
RCD but demonstrates the necessity for such tools in following
up with treatments in RCD patients.
CONCLUSIONS
This study shows that cone spacing correlated with visual
acuity in healthy subjects and RCD patients. However, as cone
spacing increased in RCD patients over time, visual acuity did
not concurrently change to reflect the progression of disease.
Likewise, OSþ thickness did not change over time in RCD
patients that demonstrated increased cone spacing, suggesting
that cone spacing Z-score measured using adaptive optics
ophthalmoscopy may be a more sensitive measure of cone loss
at the fovea than measures of visual acuity or OSþ thickness in
patients with RCD.
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